Anthony D'Adamio, SVP & General Counsel at Bioventus Inc. (BVS), sold 4,380 shares at $10.19 ($45K) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($45k) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BVS | SELL | 2024-12-26 | $123K | — | Filing → |
| BVS | SELL | 2024-06-25 | $33K | — | Filing → |
| BVS | SELL | 2024-06-21 | $132K | — | Filing → |